Replies to post #287559 on Avid Bioservices Inc (CDMO)

[pphmtoolong]

Revenue_monster, clearly Peregrine has been actively trying to monetize this discovery for months. Like you, I hope they can announce a real money partnership in time to avoid the RS.

GLTA, Paul

[biopharm]

That may be left up to Peregrine, in order to point out how leading cancer researchers have SEEN and been CONVINCED that the patent is required for all IO combos ....and/or whatever other conclusions they have come to witness (acquired adaptive immunity comes to mind..) and IF Peregrine does not bring forth leading researchers to possibly a 2nd Investment Bank to assess the TRUE market value then HOW HOW HOW can Peregrine be in negotiations with any BP at all?

You see where I am leading to ... ? One can not depend upon a BP to assess your IP market value especially when such BPs will surely undercut PS Targeting true value....

Maybe I am wrong and Peregrine in the middle to break out with some backers...and PRs to support the True value of PS Targeting IP... because CEO SK admitted in the last cc how undervalued PPHM is in regards to pps/market cap and I wonder what steps are being taken to show the world how undervalued PPHM truly is...

Delaware law talks about Fiduciary Duty and not nice being in ANY negotiations while no steps are taken to increase shareholder value....and the overall value of Avid-Peregrine and complete PS Targeting potential...

Early detection of all cancers based on Flipped PS....sounds mighty worthy to tell the world

[north40000]

I read "patent application", not "patent"---where did you see "patent"? A patent grant gives its owner(UTSW) in conjunction with its exclusive licensee(PPHM) the right to exclude others. IMO, a patent grant is easier to monetize than a patent application which itself grants nothing except inferentially as a future value should(if&when) a patent materialize.